Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Elastic NV (ESTC) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance

Elastic NVTrade
SELLAS Life Sciences Group Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Elastic NV vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Elastic NV trades at $95.26 (market cap $9.77B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: Elastic NV is far larger — about 4.3× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Elastic NV is trading nearer its 52-week high, SELLAS Life Sciences Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals.

ESTCSLS
Market Cap
$9.77B$2.28B
Volume
945,5143,128,960
Sector
TechnologyHealth
52-Week High
$99.91$15.46
52-Week Low
$43.30$1.39
Typical Hold Time
10 Days—
Enterprise Value
$8.91B$2.15B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Elastic NV

Elastic (ESTC) trades at $93.1, down 1.59% on the day, with a bullish technical outlook and strong earnings beats in recent quarters. The company shows robust revenue growth, improving profitability into 2026, and positive sentiment from analysts, with 22 buy ratings and no sells. Recent product launches, including AI-driven metrics and serverless vector database offerings, highlight innovation in its observability and search platforms.

The stock presents a growth opportunity driven by product innovation and expanding profit margins, but risks include high valuation multiples and competitive pressures in the enterprise software sector. Analyst consensus targets $79.50, below the current price, suggesting cautious optimism amid execution risks and market volatility.

SELLAS Life Sciences Group Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Elastic NV

Elastic NV provides a leading search AI platform built on Elasticsearch. Its software helps organizations find, observe, and protect data through search-powered analytics for various cloud-based applications.

Read more on ESTC →

About SELLAS Life Sciences Group Inc. Common Stock

SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.

Read more on SLS →